Home Pharmacyclics said to weigh sale of U.S. cancer drugmaker
 

Keywords :   


Pharmacyclics said to weigh sale of U.S. cancer drugmaker

2015-02-26 02:33:48| Biotech - Topix.net

Pharmacyclics, which makes a fast- growing cancer drug and is valued at more than $15 billion, is exploring options including a sale, said people with knowledge of the matter. The Sunnyvale-based drugmaker has attracted interest from companies including Johnson & Johnson and Novartis, the people said, asking not to be identified discussing private information.

Tags: us sale cancer weigh

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »